In their recent study based on statistics from 40 countries, Artaud-Wild et all mentioned that wine may be protective against coronary heart disease (CHD) mortality when the population consumed large amounts of saturated fats. This is what we had previously reported,2 suggesting that wine drinking was counteracting the effects of dairy fats and cigarette smoking.3
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The French Paradox: Vegetables or Wine
To the Editor:
In their recent study based on statistics from 40 countries, Artaud-Wild et all mentioned that wine may be protective against coronary heart disease (CHD) mortality when the population consumed large amounts of saturated fats. This is what we had previously reported,2 suggesting that wine drinking was counteracting the effects of dairy fats and cigarette smoking. 3 Nevertheless, Artaud-Wild et all concluded that it was probably the higher consumption of vegetable foods that protected France from CHD as compared with Germany, the United Kingdom, and Finland. Certainly, a high consumption of vegetable foodstuffs constitutes a healthy habit observed in Mediterranean countries. However, the question raised is whether the French paradox, that is, a high level of risk factors but the lowest mortality rate from CHD in the Western world, can be attributed to vegetable foods or to wine. In recent WHO statistics (1987 to 1989),4 the agestandardized mortality rate from CHD for men was 99 (per 100 000) for France, 111 for Spain, 143 for Italy, and 133 for Greece. In these countries, the consumption of vegetable foods (vegetables plus vegetable fats plus fruit) was respectively 470, 697, 985, and 1287 calories per day for 1985 to 1988. 5 Thus, an adequate comparison should be provided not by selecting countries but by studying countries similar in development and reliability of statistics, for example, the 23-member countries of the OECD.5 WHO4 reported the annual mortality statistics for 22 of these 23 countries, and 21 (excluding Japan, using sake instead) consumed at least 10 g of wine per person per day.5 6 In these 21 countries used in the present study, the univariate correlation coefficients between CHD mortality and the intake of various foodstuffs were as follows: vegetables, -0.48 (P<.05); vegetable fats, -0.44 (P<.05); fruit, -0.28 (NS); dairy products, 0.66 (P<.001); and wine, -0.87 (P<.001). For wine consumption, the log was used because the inverse relation between wine and CHD mortality is not linear but exponential. In stepwise multivariate regression analysis, only two foodstuffs were still significantly correlated with CHD mortality, namely, dairy products(+) (P<.05) and wine(-) (P<.001), with a multiple r=.90 (P<.0001). In the last 5 years, prospective studies on a total of more than 600 000 subjects7 have consistently shown that moderate alcohol drinking was associated with a 20% to 60% lower risk of CHD. In addition, in a study on 128 934 adults,8 wine drinkers had a 30% to 40% lower risk for cardiovascular death compared with liquor drinkers.
In conclusion, further epidemiologic studies are certainly required to elucidate the protection afforded by wine on CHD. Nevertheless, in the 21 most industrialized countries drinking wine, the protective effect of wine appears to be much more convincing than that of other vegetable foods. This is especially true in France,23 with the largest consumption of wine in the world.
Serge Renaud
Jean-Claude Ruf INSERM, Unit 63 Lyon-Bron, France
Reply
We appreciated the comments of Drs Renaud and Ruf about nutritional factors and coronary mortality in 40 countries including France and Finland. We suggested that differences in coronary heart disease (CHD) mortality rates in the 40 countries reported in our article could be partly explained by intakes of milk, butterfat, and vegetable foods (particularly vegetable oils and vegetables). Our study suggested that the association of dietary factors with CHD mortality is most complex and that differences in coronary mortality cannot be ascribed to one nutrient or to one food only. We do not think the answer is as simple as "vegetables" or "wine," as suggested by Drs Renaud and Ruf.
One of the ways our study was different from many of the previously reported studies was that it included a much broader representation of countries. This allowed for determining nutrients and foods associated with CHD mortality in countries in which considerable amounts of cholesterol and saturated fat were consumed, in those countries in which lesser amounts of cholesterol and saturated fat were consumed, and for all of the countries combined. In our study, the foods associated with CHD mortality in the 18 countries that had the higher intakes of cholesterol and saturated fat were basically the same foods referred to in Drs Renaud and Rufs letter as being associated with CHD mortality in 23 countries of similar development.
It was also stated in our article that, when we considered only the 18 countries with the higher intakes of cholesterol and saturated fat and adjusted for these nutrients, wine was inversely and significantly related to CHD mortality. This is not different from the point made by Drs Renaud and Ruf that wine drinking was associated with a lower risk for cardiovascular disease. However, the other side of the coin is that, in our study, wine was not related to CHD mortality in the other 22 countries with the lower intakes of cholesterol and saturated fat. Our data then suggest at least two possibilities: First, to lower one's coronary risk, add wine to an otherwise atherogenic diet. Second and more significantly would be a change of eating habits to reflect a lower fat, higher complex carbohydrate diet. If one takes into account the gamut of the diseases people die from as well as the number of alcoholrelated deaths, it seems reasonable to consider the second possibility as most useful. Diet in many clinical trials has been shown to be effective in reducing coronary events, whereas there is no clinical trial of the wine hypothesis. Drinking some wine to enhance the pleasure of one's meal is certainly an appropriate thing to do. Drinking quantities of wine with the idea of offsetting cigarette smoking and the atherogenic and other deleterious effects of cholesterol and saturated fat is not, in our opinion, a good choice. The final line in our article still holds true. "It is necessary to consider the total diet." Fig 2A of the paper, the authors show that combined antioxidant supplementation of 12 subjects for 12 weeks leads to decreased susceptibility of LDL to Cu2+-catalyzed formation of thiobarbituric acid-reactive substances (TBARS, an indirect measure of lipid peroxidation) compared with LDL from 12 placebo-treated control subjects. Fig 3A apparently is a further analysis of these data and shows that after 12 weeks of supplementation there is a 2.1-fold prolongation in the lag phase preceding the rapid propagation phase of TBARS formation in LDL from the combined antioxidant group compared with the placebo group. In contrast, the data in Fig 2A indicate that the lag phases for the two groups are virtually identical: by extending the time course curves of TBARS formation during the propagation phase through the abscissa, we estimate that the lag phases are approximately 0.7 h for each group, instead of about 0.9 and 1.9 h for the placebo and combined antioxidant groups, respectively, as shown in Fig 3A. How can these differences be reconciled?
Similarly, in Table 3 of the article the authors show that in a parallel study using supplementation with a-tocopherol alone, the lag phase increased from 0.86±0.03 h at baseline to 1.90+0.28 h after 12 weeks of supplementation, referring to their previous publication in J Lipid Res.2 Again, when we looked up this reference, the data presented did not support this increase in lag phase (see Figs 2A and 4A of Jialal and Grundy2). From these figures, we estimate that the lag phase after a-tocopherol supplementation for 12 weeks is approximately 0.8 h, i.e. similar to the lag phase at baseline and also in the placebo group, both at baseline and after 12 weeks.
In summary, we believe that these data presented by Jialal and Grundy"2 do not support the conclusion that a-tocopherol or combined antioxidant supplementation for 12 weeks increases the resistance of LDL to Cu2+-induced oxidation as assessed by ex vivo measurement of the lipid peroxidation lag phase. Lack of an effect of a-tocopherol supplementation on the lag phase of LDL oxidation would be inconsistent with other studies,3-5 and, therefore, may initiate a debate over the usefulness of antioxidant supplementation as a clinical adjunct in the prevention or treatment of atherosclerotic vascular disease. 
Previously we have shown that high dose a-tocopherol alone, and in combination with ,-carotene and ascorbate, decreases the susceptibility of LDL to oxidation as evidenced by lower mean values during the time course curves, increased lag phases, and decreased oxidation rates by both the thiobarbituric acid reacting substances assay and the formation of conjugated dienes.1,2 Frei and Lynchl2 have raised certain issues regarding our publications on dietary antioxidant supplementation in human volunteers. They suggest a discrepancy between the time course curve of oxidation shown in Fig 2 and the lag phase of oxidation shown in They conducted a rough extrapolation of the mean data and came to the conclusion that the lag phase is not different between the supplemented and placebo groups. We do not believe that it is valid to determine from the mean data the lag phase and the oxidation rate. As clearly noted in our manuscript, we subjected the individual time course curves of each subject at baseline and at 12 weeks to a best fit curve. The best fit curve was generated for each subject's time course curve using a spline function (Deltagraph software). This procedure was described in more detail in another report3; from the best fit curve the lag phase was obtained by drawing a tangent to the curve at the propagation phase of oxidation and extrapolating it to the horizontal axis. The rate of LDL oxidation was determined from the propagation phase of the time course curve. At baseline, the mean values for the lag phase obtained in the three groups using this methodology were as follows: placebo, 50.4 minutes; the a-tocopherol group, 46.8 minutes; and the combined antioxidant group, 51.3 minutes. These values are clearly within the range reported in the most extensive investigation of the lag phase by Esterbauer's group4 in 72 samples; range (34 to 114 minutes), mean+±SD 68 ±+15 minutes. Thus the methodology we are using to compute the propagation rate and the lag phase appears to be appropriate. We do not believe that rough extrapolation of the data in Fig 2' would allow a precise estimation of the lag phase, given they lack the individual data. Therefore, we are now providing the individual data on all subjects at 3 months (Table) . It is apparent that the lag times are higher in the supplemented groups.
The second point that Frei and Lynch raised is that in our previous publication in the Journal ofLipid Research,2 there was no change in the lag phase and that their interpretation of the data was that a-tocopherol supplementation does not lead to increased resistance of LDL to copper catalyzed oxidation. These workers have failed to take into account some of the results presented in this manuscript. For example, while they refer to the data in Fig 2a  and 4a,2 and suggest that the data does not support an increase in lag phase, they ignore the data in Fig 3a and Table 3 .2 In fact we have no disagreement that the data in Fig 2a does not support a difference in the time course curve or in the kinetics of oxidation (lag phase and oxidation rate) because this represents the time course curves of the two groups at baseline and this obviously was expected. However, it is clear in both Fig 3 (6 weeks) and Fig 4 ( 12 weeks) in this report that the time course curves are different in the group that was supplemented with a-tocopherol alone, and in fact, the significantly lower mean values are clearly denoted by asterisks in the time course curves. Once again, as stated above, the kinetics of oxidation were obtained by subjecting the individual
